Hutch News

Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection

Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection

Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
Hutch NewsOctober 11, 2024
Herpes cure with gene editing makes progress in laboratory studies

Herpes cure with gene editing makes progress in laboratory studies

Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
News ReleasesMay 13, 2024
Sleuthing the immune system’s mysterious T-regs

Sleuthing the immune system’s mysterious T-regs

Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
Hutch NewsDecember 10, 2021
Scientists predict progress against COVID-19, cancer in 2021

Scientists predict progress against COVID-19, cancer in 2021

After a challenging and deadly 2020, some hopeful predictions for the new year
Hutch NewsDecember 22, 2020
A year of research dominated by the coronavirus

A year of research dominated by the coronavirus

Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Hutch NewsDecember 21, 2020
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more

Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more

Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
News ReleasesSeptember 01, 2020
A cure for herpes? There is progress to report

A cure for herpes? There is progress to report

Mouse studies show gene therapy can cause big drop in latent infections
Hutch NewsAugust 18, 2020
¿La cura del herpes? Hay avances que reportar

¿La cura del herpes? Hay avances que reportar

Los estudios con ratones muestran que la terapia génica puede reducir muchísimo las infecciones inactivas
Hutch NewsAugust 18, 2020
Antibody blocks Epstein-Barr virus in preclinical trial

Antibody blocks Epstein-Barr virus in preclinical trial

Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Hutch NewsJune 23, 2020
Correlation is not (necessarily) causation

Correlation is not (necessarily) causation

Or, how we know herpes doesn’t cause cervical cancer — and HPV does
Hutch NewsFebruary 13, 2020
Rethinking an old viral foe

Rethinking an old viral foe

Why does a common virus plague bone marrow transplant patients? New study challenges dogma, opens door to new therapies.
Hutch NewsJanuary 17, 2019
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award

Dr. Joshua Hill receives Amy Strelzer Manasevit grant award

Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
Hutch NewsJune 06, 2018
When scientific hypotheses don’t pan out

When scientific hypotheses don’t pan out

Research studies are often built around an educated guess. What happens when those guesses are wrong?
Hutch NewsFebruary 16, 2018
Stealing a secret from an unwelcome virus

Stealing a secret from an unwelcome virus

An unexpected discovery in a herpes lab might bring relief to cancer patients
Hutch NewsJune 29, 2017
Experimental herpes drug pritelivir more effective than standard treatment

Experimental herpes drug pritelivir more effective than standard treatment

Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
Hutch NewsDecember 20, 2016
Can gene editing cure herpes?

Can gene editing cure herpes?

Fred Hutch study shows ‘pathway to potential cure’ for herpes simplex and other latent viruses
Hutch NewsSeptember 08, 2016